Affiliation:
1. World Health Organization Regional Office for Africa
2. World Health Organization
Abstract
Abstract
Universal access to childhood vaccination is important to child health and sustainable development. Here we identify, at a fine spatial scale, under-immunized children and zero-dose children. Using Chad, as an example, the most recent nationally representative household survey that included recommended vaccine antigens was assembled. Age-disaggregated population (12-23 months) and vaccination coverage were modelled at a fine spatial resolution scale (1km x 1 km) using a Bayesian geostatistical framework adjusting for a set of parsimonious covariates. There was a variation at fine spatial scale in the population 12-23 months a national mean of 18.6% (CrI 15.8% – 22.6%) with the highest proportion in the South-East district of Laremanaye 20.0% (14.8 – 25.0). Modelled coverage at birth was 49.0% (31.2% - 75.3%) for BCG, 44.8% (27.1 – 74.3) for DPT1, 24.7% (12.5 – 46.3) for DPT3 and 47.0% (30.6 – 71.0) for measles (MCV1). Combining coverage estimates with the modelled population at a fine spatial scale yielded 312,723 (Lower estimate 156,055 - 409,266) zero-dose children based on DPT1. Improving routine immunization will require investment in the health system as part of improving primary health care. Uncertainty highlights areas requiring further investigation and quality data to better understand coverage.
Publisher
Research Square Platform LLC
Reference61 articles.
1. World Health Organization. 2021 Immunization Agenda 2030: A Global Strategy To Leave No One Behind. (Geneva.
2. GAVI. 2021 Prevent, Protect Prosper. (Geneva.
3. UN. 2023 The Sustainable Development Goals Report 2023: Towards a Rescue Plan for People and Planet. (New York, United Nations Statistics Division.
4. UN. 2023 The Sustainable Development Goals Report 2023. (New York.
5. Defining the Zero Dose Child: A Comparative Analysis of Two Approaches and Their Impact on Assessing the Zero Dose Burden and Vulnerability Profiles across 82 Low- and Middle-Income Countries;Wonodi C;Vaccines (Basel),2023